MOESM3 of Integrative Molecular Analysis of Metastatic Hepatocellular Carcinoma

Dongfang Wang,Yanjing Zhu,Jing Tang,Qiuyu Lian,Guijuan Luo,Wen,Michael J. Zhang,Hongyang Wang,Lei Chen,Jun Gu

DOI: https://doi.org/10.6084/m9.figshare.10303253

2019-01-01

Abstract:Additional file 3: Table S2. siRNA design.

What problem does this paper attempt to address?

MOESM3 of M6a Mrna Methylation Regulates CTNNB1 to Promote the Proliferation of Hepatoblastoma

Li Liu,Jing Wang,Guifeng Sun,Qiong Wu,Jing Ma,Xin Zhang,Nan Huang,Zhixuan Bian,Song Gu,Mingwei Xu,Minzhi Yin,Fenyong Sun,Qiuhui Pan

DOI: https://doi.org/10.6084/m9.figshare.11446419

2019-01-01

Abstract:Additional file 3: Table S1. Sequence of primers used in this study.
MOESM3 of EZH2 Negatively Regulates PD-L1 Expression in Hepatocellular Carcinoma

Gang Xiao,Li-Lian Jin,Chaoqun Liu,Yongchun Wang,Ya-Ming Meng,Zhongguo Zhou,Jing Chen,Xing-Juan Yu,Yaojun Zhang,Jiacheng Xu,Limin Zheng

DOI: https://doi.org/10.6084/m9.figshare.10310153

2019-01-01

Abstract:Additional file 3: Table S7. The genes predicted in Fig. 3c.
MOESM2 of Molecular Analysis of Cell-Free DNA Identifies Distinct Molecular Features in Patients with Chemosensitive and Chemorefractory Small Cell Lung Cancer

Jie Zhang,Chen Tian,Fang Lv,Jianfei Wang,Wenbo Han,Jing Nie,Liping Dai,Weiheng Hu,Xiaoling Chen,Xiao Ma,Guangming Tian,Di Wu,Shiyu Han,Yang Wang,Jieran Long,Ziran Zhang,Jian Fang,Henghui Zhang

DOI: https://doi.org/10.6084/m9.figshare.10038323

2019-01-01

Abstract:Additional file 2: Table S1. List of 1084 detected genes in the initial panel (in alphabetical order).
Supplementary Materials and Methods from Loss of SNAIL Regulated Mir-128-2 on Chromosome 3p22.3 Targets Multiple Stem Cell Factors to Promote Transformation of Mammary Epithelial Cells

PengXu Qian,Arindam Banerjee,Zheng-Sheng Wu,Xiao Zhang,Hong Wang,Vijay Pandey,Wei-Jie Zhang,Xue-Fei Lv,Sheng Tan,Peter E. Lobie,Tao Zhu

DOI: https://doi.org/10.1158/0008-5472.22395995

2023-01-01

Abstract:PDF file - 190K, Includes patient and specimen data, reagent information, miRNA and siRNA transfection, and statistical analysis. Also includes supplementary references
MOESM2 of Lectin Array and Glycogene Expression Analyses of Ovarian Cancer Cell Line A2780 and Its Cisplatin-Resistant Derivate Cell Line A2780-cp

Ruihua Zhao,Wenjun Qin,Ruihuan Qin,Jian Han,Can Li,Yisheng Wang,Congjian Xu

DOI: https://doi.org/10.6084/m9.figshare.c.3786353_d2

2017-01-01

Abstract:Additional file 2. Primer sequences.
MOESM5 of M6a Mrna Methylation Regulates CTNNB1 to Promote the Proliferation of Hepatoblastoma

Li Liu,Jing Wang,Guifeng Sun,Qiong Wu,Jing Ma,Xin Zhang,Nan Huang,Zhixuan Bian,Song Gu,Mingwei Xu,Minzhi Yin,Fenyong Sun,Qiuhui Pan

DOI: https://doi.org/10.6084/m9.figshare.11446437

2019-01-01

Abstract:Additional file 5: Table S3. Targets sequences of siRNAs used in this study.
Identification of Molecular Subtypes for Integrated Multi-Omics Analysis for Use in Guiding Precision Medicine in Hepatocellular Carcinoma.

Yihong Chen,Ying Han,Changjing Cai,Yinghui Peng,Jiayao Ma,Hong Shen,Shan Zeng

DOI: https://doi.org/10.1200/jco.2024.42.16_suppl.2576

IF: 45.3

2024-01-01

Journal of Clinical Oncology

Abstract:2576 Background: Tumor microenvironment (TME) heterogeneity leads to the discrepancy of survival prognosis and clinical treatment response for HCC patients. Although the documented molecular subtypes moderately describe the TME heterogeneity and characteristics, their clinical application is constrained by several issues. Methods: We integrated three single-cell datasets from 39 HCC patients to describe the TME landscape and identified prognosis-related cell subclusters. Unsupervised clustering of subcluster-specific markers (SSMs) was performed to generate transcriptomic subtypes. The predictive value of these molecular subtypes for prognosis and treatment response was explored in multiple external HCC cohorts and Xiangya real-world HCC cohort with patients who received immune checkpoint blockade (ICB) therapy. Cancer stemness was estimated using bioinformatic methods and in vivo and in vitro experiments. The features of TME were further validated using single-cell RNA-seq and immune repertoire sequencing, mass cytometry (CyTOF) and multiplex immunofluorescence (mIF). Ultimately, we constructed prognosis-related score (PRS)based on machine learning algorithm, and identified the potential therapeutic targets and agents for high-PRS patients. Results: The comprehensive single-cell analysis provided a high-resolution depiction of TME heterogeneity in HCC and confirmed 6 cell subclusters of prognostic relevance. Five transcriptomic subtypes were constructed using SSMs, which possessed different clinical prognosis, stemness characteristics, immune landscape and therapeutic responses. Class 1 indicated an inflamed phenotype with better clinical outcomes, while Class 2 and class 4 demonstrated immune-deserted phenotypes lacking T cells infiltration. Class 5 and class 3 indicated inhibitory tumor immune microenvironment enriched regulatory T cells and suppressive immune checkpoints. Multiple therapeutic cohorts suggested that Class 5 and class 3 were sensitive to ICB and targeted therapy, while Class 1 and Class 2 were more responsive to transcatheter arterial chemoembolization treatment (TACE). Class 4 displayed resistant to all conventional HCC therapies. The PRS performed well in prognostic prediction in multiple HCC cohorts. Four potential therapeutic agents and four targets were further identified for high-PRS HCC patients. Conclusions: Our study generated a clinically valid molecular classification, thereby providing guidance for precision medicine in HCC patients.
Supplementary Table 1 from A Regulatory Loop Involving miR-22, Sp1, and c-Myc Modulates CD147 Expression in Breast Cancer Invasion and Metastasis

Ling-Min Kong,Cheng-Gong Liao,Yang Zhang,Jing Xu,Yu Li,Wan Huang,Yi Zhang,Huijie Bian,Zhi-Nan Chen

DOI: https://doi.org/10.1158/0008-5472.22402862

2023-01-01

Abstract:PDF file - 75K, Oligonucleotide sequence of PCR primers and siRNA fragments.
Identification and Functional Evaluation of Mir-4633-5p As a Biomarker and Tumor Suppressor in Metastatic Melanoma

Bingqing Zou,Wenjia Zhu,Hongqin Liu,Shuyi Wang,Hongguang Zhu

DOI: https://doi.org/10.1159/000493414

2018-01-01

Cellular Physiology and Biochemistry

Abstract:Background/Aims: Sinonasal mucosal melanoma (SMM) is a rare but extremely aggressive disease. Interestingly, however, as lethal as SMM, a few patients could survive for over 5 years without metastasis. However, biomarkers for metastatic SMM are lacking. Methods: Laser-capture microdissection combined with microRNA microarray and RT-qPCR was performed in formalin-fixed paraffin-embedded tissue samples from SMM patients whose follow-up studies were carried out in parallel. In vitro cell proliferation and invasion assays, gelatin zymography, western blot analysis and RT-qPCR were performed in melanoma cell lines. Results: In the discovery stage, miR-4633-5p expressed differentially in sinonasal mucosal melanoma patients with short and long disease-specific survival. Subsequent large-sample validation revealed that expression of miR-4633-5p was lower in metastatic SMM than in non-metastatic patients (P< 0.001). Moreover, miR-4633-5plow was able to identify metastatic SMM with specificity of 100% (5/5) and sensitivity of 87.5% (21/24). Multivariate analysis further pinpointed miR-4633-5p as an independent marker for metastasis (relative risk: 54.22, P< 0.001). In vitro, overexpression of miR-4633-5p suppressed the growth and invasiveness of melanoma cells through inhibiting activation of Akt pathway and secretion of MMP2, while knockdown of miR-4633-5p reversed the inhibitory effects. Conclusion: Our findings underpin miR-4633-5p as a predictive biomarker in metastatic SMM and a pivotal tumor suppressor that negatively regulates the invasive growth of melanoma cells. Quantitative detection of miR-4633-5p can diagnostically predict the risk of metastasis in SMM patients, which, in turn, may lead to more personalized treatment with better prognosis.
Supplementary Figures 1-2 from Inhibition of Growth and Metastasis of Human Hepatocellular Carcinoma by Antisense Oligonucleotide Targeting Signal Transducer and Activator of Transcription 3

Wenchang Li,Sheng‐Long Ye,Rong Sun,Yinkun Liu,Zhao–You Tang,Youngsoo Kim,James G. Karras,Hong Zhang

DOI: https://doi.org/10.1158/1078-0432.22441243

2023-01-01

Abstract:Supplementary Figures 1-2 from Inhibition of Growth and Metastasis of Human Hepatocellular Carcinoma by Antisense Oligonucleotide Targeting Signal Transducer and Activator of Transcription 3
Supplemental Tables from Demethylation-Induced Overexpression of Shc3 Drives c-Raf–Independent Activation of MEK/ERK in HCC

Yun Liu,Xinran Zhang,Baicai Yang,Hao Zhuang,Hua Guo,Wen Wei,Yuan Li,Ruibing Chen,Yongmei Li,Ning Zhang

DOI: https://doi.org/10.1158/0008-5472.22418658

2023-01-01

Abstract:<p>This file contains all Supplemental tables that including clinicopathological information of HCC tissue samples and sequences of DNA primer, siRNAs, and shRNAs.</p>
MOESM3 of Exosomal Circrna-100338 Promotes Hepatocellular Carcinoma Metastasis Via Enhancing Invasiveness and Angiogenesis

Xiu-Yan Huang,Zili Huang,Jin Huang,Bin Xu,Xinyu Huang,Yifeng Xu,Jing Zhou,Zhao–You Tang

DOI: https://doi.org/10.6084/m9.figshare.11707323

2020-01-01

Abstract:Additional file 3: Figure S2A. Relative expression of circRNA-100,338, Figure S2B. Relative expression of circRNA-100,338, Figure S2C. The number of invaded cells (n), Figure S2D. The number of invaded cells (n), Figure S2F. MMP9 activity (ng/mL), Figure S2G. MMP9 activity (ng/mL)
Supplementary Figures 1-3, Table 1 from A Unique Metastasis Gene Signature Enables Prediction of Tumor Relapse in Early-Stage Hepatocellular Carcinoma Patients

Stephanie Roessler,Jia Huang,Anuradha Budhu,Marshonna Forgues,Qing–Hai Ye,Ju-Seog Lee,Snorri S. Thorgeirsson,Zhongtang Sun,Zhao‐You Tang,Lun‐Xiu Qin,Xin Wei Wang

DOI: https://doi.org/10.1158/0008-5472.22387784.v1

2023-01-01

Abstract:Supplementary Figures 1-3, Table 1 from A Unique Metastasis Gene Signature Enables Prediction of Tumor Relapse in Early-Stage Hepatocellular Carcinoma Patients
MOESM3 of Global Impact of Somatic Structural Variation on the DNA Methylome of Human Cancers

Yiqun Zhang,Lixing Yang,Melanie H. Kucherlapati,Angela Hadjipanayis,Angeliki Pantazi,Christopher A. Bristow,Eunjung Lee,Harshad S. Mahadeshwar,Jiabin Tang,Jianhua Zhang,Sahil Seth,Semin Lee,Xiaojia Ren,Xingzhi Song,Huandong Sun,Jonathan G. Seidman,Lovelace J. Luquette,Ruibin Xi,Lynda Chin,Alexei Protopopov,Peter J. Park,Raju Kucherlapati,Chad J. Creighton

DOI: https://doi.org/10.6084/m9.figshare.9980411

2019-01-01

Abstract:Additional file 3. Related to Fig. 1. SSV calls by Meerkat for 827 TCGA cases with high pass WGS data, for 761 of which RNA-seq data were available for analysis as part of the total combined set of 2334 cases.
MOESM6 of Exosomal Circrna-100338 Promotes Hepatocellular Carcinoma Metastasis Via Enhancing Invasiveness and Angiogenesis

Xiu-Yan Huang,Zili Huang,Jin Huang,Bin Xu,Xinyu Huang,Yifeng Xu,Jing Zhou,Zhao–You Tang

DOI: https://doi.org/10.6084/m9.figshare.11707341

2020-01-01

Abstract:Additional file 6: Figure S5A. Relative expression of exosomal circRNA-100,338, Figure S5C. Tumor volume (cm3), Figure S5D. MVD (n), Figure S5E. MMP9 level by ELISA analysis (ng/mg protein), Figure S5F. The mean number of lung metastatic nodules (n), Figure S5G. Percentage of Ki67 in lung metastatic nodules (%)
MOESM9 of Comprehensive Molecular Characterization of Inhibitors of Apoptosis Proteins (iaps) for Therapeutic Targeting in Cancer

Jianfeng Liang,Wanni Zhao,Pan Tong,Ping Li,Yuanli Zhao,Hua Li,Jun Liang

DOI: https://doi.org/10.6084/m9.figshare.11686629

2020-01-01

Abstract:Additional file 9: Table S4. Sample size for TCGA tumor vs adjacent normal comparisons.
Additional File 3 of Bioinformatics Integrated Analysis to Investigate Candidate Biomarkers and Associated Metabolites in Osteosarcoma

Jun Wang,Mingzhi Gong,Zhenggang Xiong,Yangyang Zhao,Deguo Xing

DOI: https://doi.org/10.6084/m9.figshare.14913465

2021-01-01

Abstract:Additional file 3: Table S1. Survival data and results for survival analysis of all feature genes.
MOESM2 of MiR-369-3p Participates in Endometrioid Adenocarcinoma Via the Regulation of Autophagy

Ping Liu,Chong Ma,Qing Wu,Wenying Zhang,Cao Wang,Yuan Li,Xiaowei Xi

DOI: https://doi.org/10.6084/m9.figshare.8863001

2019-01-01

Abstract:Additional file 2: Table S2. Three GO terms, (1) regulation of Ras GTPase activity, (2) regulation of neuroblast proliferation, and (3) regulation of cellular catabolic process, were statistically significant with p
Additional File 3 of Identification of RNA-splicing Factor Lsm12 As a Novel Tumor-Associated Gene and a Potent Biomarker in Oral Squamous Cell Carcinoma (OSCC)

Dong Yan,Liyan Xue,Yan Zhang,Yanguang Zhang,Jian Zhang,Hui Li,Yan Wang,Caiyun Liu,Na Jiang,Xiao-Yan Ma,Xiaoyan Ma,Xiao Ma,Fangyu Chen,Lingxia Li,Liyuan Yu,Xuefeng Liu,Shujuan Shao,Shufang Guan,Qingchun Xiao,Ailing Dong,Lijie Huang,Chenyang Shi,Ming Fu,Ning Lv,Qimin Zhan

DOI: https://doi.org/10.6084/m9.figshare.19633851

2022-01-01

Abstract:Additional file 3: Table S2. Upregulated genes in the animal model of OSCC tumorigenesis.
Additional File 3 of Characterization and Application of a Lactate and Branched Chain Amino Acid Metabolism Related Gene Signature in a Prognosis Risk Model for Multiple Myeloma

Zhengyu Yu,Bingquan Qiu,Huapeng Zhou,Linfeng Li,Ting Niu

DOI: https://doi.org/10.6084/m9.figshare.23949598

2023-01-01

Abstract:Additional file 3: Table S3 siRNA sequences

MOESM3 of Integrative Molecular Analysis of Metastatic Hepatocellular Carcinoma

MOESM3 of M6a Mrna Methylation Regulates CTNNB1 to Promote the Proliferation of Hepatoblastoma

MOESM3 of EZH2 Negatively Regulates PD-L1 Expression in Hepatocellular Carcinoma

MOESM2 of Molecular Analysis of Cell-Free DNA Identifies Distinct Molecular Features in Patients with Chemosensitive and Chemorefractory Small Cell Lung Cancer

Supplementary Materials and Methods from Loss of SNAIL Regulated Mir-128-2 on Chromosome 3p22.3 Targets Multiple Stem Cell Factors to Promote Transformation of Mammary Epithelial Cells

MOESM2 of Lectin Array and Glycogene Expression Analyses of Ovarian Cancer Cell Line A2780 and Its Cisplatin-Resistant Derivate Cell Line A2780-cp

MOESM5 of M6a Mrna Methylation Regulates CTNNB1 to Promote the Proliferation of Hepatoblastoma

Identification of Molecular Subtypes for Integrated Multi-Omics Analysis for Use in Guiding Precision Medicine in Hepatocellular Carcinoma.

Supplementary Table 1 from A Regulatory Loop Involving miR-22, Sp1, and c-Myc Modulates CD147 Expression in Breast Cancer Invasion and Metastasis

Identification and Functional Evaluation of Mir-4633-5p As a Biomarker and Tumor Suppressor in Metastatic Melanoma

Supplementary Figures 1-2 from Inhibition of Growth and Metastasis of Human Hepatocellular Carcinoma by Antisense Oligonucleotide Targeting Signal Transducer and Activator of Transcription 3

Supplemental Tables from Demethylation-Induced Overexpression of Shc3 Drives c-Raf–Independent Activation of MEK/ERK in HCC

MOESM3 of Exosomal Circrna-100338 Promotes Hepatocellular Carcinoma Metastasis Via Enhancing Invasiveness and Angiogenesis

Supplementary Figures 1-3, Table 1 from A Unique Metastasis Gene Signature Enables Prediction of Tumor Relapse in Early-Stage Hepatocellular Carcinoma Patients

MOESM3 of Global Impact of Somatic Structural Variation on the DNA Methylome of Human Cancers

MOESM6 of Exosomal Circrna-100338 Promotes Hepatocellular Carcinoma Metastasis Via Enhancing Invasiveness and Angiogenesis

MOESM9 of Comprehensive Molecular Characterization of Inhibitors of Apoptosis Proteins (iaps) for Therapeutic Targeting in Cancer

Additional File 3 of Bioinformatics Integrated Analysis to Investigate Candidate Biomarkers and Associated Metabolites in Osteosarcoma

MOESM2 of MiR-369-3p Participates in Endometrioid Adenocarcinoma Via the Regulation of Autophagy

Additional File 3 of Identification of RNA-splicing Factor Lsm12 As a Novel Tumor-Associated Gene and a Potent Biomarker in Oral Squamous Cell Carcinoma (OSCC)

Additional File 3 of Characterization and Application of a Lactate and Branched Chain Amino Acid Metabolism Related Gene Signature in a Prognosis Risk Model for Multiple Myeloma